2’-Fluoro-a-l-RNA-Modified Oligonucleotides
was stirred for 2 h whereupon sat. aq. NaHCO3 (50 mL) was added.
The reaction mixture was stirred for additional 10 min followed by
extraction with EtOAc (150 mL). The organic phase was washed
with H2O (5ꢂ100 mL). The organic phase was dried (Na2SO4), fil-
tered and evaporated to dryness under reduced pressure. The resi-
due was purified by silica gel column chromatography by using as
eluent EtOAc (0–50%) in PE to afford compound 3 as a colorless
CDCl3): d=À185.5; elemental analysis calcd (%) for
C32H33FN2O6·1= EtOAc: C 68.13, H 6.03, N 4.84; found: C 67.77, H
5
5.65, N 4.69; ESI-HRMS: m/z 583.2219 ([M+Na]+, C32H33FN2O6·Na
calcd 583.2215).
1-(2-Deoxy-2-fluoro-a-l-ribofuranosyl)thymine (6): Compound 5
(720 mg, 1.28 mmol) was dissolved in anhyd. CH2Cl2 (50 mL) and
the solution was stirred and cooled to À788C by using dry ice and
acetone. Boron trichloride (1.0m solution in CH2Cl2, 10.2 mL,
10.2 mmol) was added dropwise and the reaction mixture was
stirred for 30 min at À788C. Afterwards, MeOH (25 mL) was added
and the resulting mixture was allow to warm to room temperature.
The reaction mixture was evaporated to dryness under reduced
pressure and the residue was redissolved in H2O (50 mL) and the
resulting mixture was stirred for 22 h at room temperature. The
mixture was then evaporated to dryness under reduced pressure
and the residue was coevaporated with anhyd. MeCN (3ꢂ20 mL).
The residue was purified by silica gel column chromatography by
using as eluent MeOH (10%) in CH2Cl2 to afford nucleoside 6 as a
white foam (258 mg; 77%). 1H NMR (400 MHz, CD3CN): d=9.21
(brs, 1H; NH), 7.37 (dd, J=2.3, 1.1 Hz, 1H; H6), 5.95 (dd, J=16.7,
2.6 Hz, 1H; H1’), 5.15 (dt, J=51.4, 2.8 Hz, 1H; H2’), 4.40–4.26 (m,
2H; H3’ and H4’), 3.85 (d, J=4.1 Hz, 1H; 3’-OH), 3.65–3.54 (m, 2H;
H5’), 3.06 (t, J=5.9 Hz, 1H; 5’-OH), 1.83 (d, J=1.2 Hz, 3H; Me);
13C NMR (101 MHz, CD3CN): d=164.8 (C=O), 151.6 (C=O), 137.7
(C6), 111.1 (C5), 101.0 (d, J=184.9 Hz, C2’), 90.8 (d, J=37.0 Hz, C1’),
88.6 (d, J=3.8 Hz, C4’), 74.9 (d, J=24.8 Hz, C3’), 62.1 (d, J=1.8 Hz,
C5’), 12.5 (Me); 19F NMR (376 MHz, CD3CN): d=À189.33; elemental
analysis calcd (%) for C10H13FN2O5: C 46.16, H 5.04, N 10.77; found:
C 45.78, H 4.95, N 10.50; ESI-HRMS: m/z 283.0700 ([M+Na]+,
C10H13FN2O5·Na calcd 283.0701).
1
oil (1.78; 94%). H NMR (400 MHz, CDCl3): d=7.39–7.21 (m, 16H;
Ph and H6), 6.13 (d, J=1.9 Hz, 1H; H1’), 5.46 (q, J=9.7 Hz, 2H;
NCH2), 5.29 (d, J=8.7 Hz, 1H; H2’), 4.70–4.48 (m, 7H; H4’ and 3ꢂ
OCH2), 4.07 (s, 1H; H3’), 3.58 (dd, J=10.0, 5.7 Hz, 1H; H5’a), 3.51
(dd, J=10.0, 6.6 Hz, 1H; H5’b), 1.99 (s, 3H; Me), 1.82 (s, 3H; Me);
13C NMR (101 MHz, CDCl3): d=169.6 (C=O), 163.4 (C=O), 151.0 (C=
O), 138.0 (Ph), 137.6 (Ph), 136.9 (Ph), 134.6 (C6), 128.5 (Ph), 128.3
(Ph), 128.1 (Ph), 128.0 (Ph), 127.8 (Ph), 127.7 (Ph), 127.6 (Ph), 110.2
(C5), 90.5 (C1’), 85.4 (C4’), 82.3 (C3’), 80.5 (C2’), 73.5(CH2), 72.1(CH2),
72.0 (CH2), 70.5 (CH2), 69.2 (C5’), 20.7 (Me), 13.2 (Me); elemental
analysis calcd (%) for C34H36N2O8·1= H2O: C 66.98, H 6.12, N 4.59;
2
found: C 66.61, H 5.80, N 4.29; ESI-HRMS: m/z 623.2350 ([M+Na]+,
C34H38N2O8·Na calcd 623.2364).
1-(3,5-Di-O-benzyl-a-l-arabinofuranosyl)-3-(benzyloxymethyl)-
thymine (4): Compound 3 (1.70 g, 2.83 mmol) was dissolved in
CH2Cl2 (20 mL) and sat. methanolic ammonia (60 mL) was added
and the reaction mixture was stirred at room temperature for 4 h.
The solution was evaporated to dryness under reduced pressure.
The residue was purified by silica gel column chromatography by
using as eluent EtOAc (0–50%) in PE to give compound 4 as a
1
white foam (1.56 g; 99%). H NMR (400 MHz, CDCl3): d=7.42–7.17
(m, 16H; Ph and H6), 5.94 (d, J=1.5 Hz, 1H; H1’), 5.49 (q, J=
9.7 Hz, 2H; NCH2), 4.72–4.48 (m, 7H; H4’ and 3ꢂOCH2), 4.29 (d, J=
8.6 Hz, 1H; H2’), 4.18 (d, J=8.6 Hz, 1H; 2’-OH), 4.05–4.02 (m, 1H;
H3’), 3.75 (dd, J=10.6, 2.9 Hz, 1H; H5’a), 3.65 (dd, J=10.6, 3.3 Hz,
1H; H5’b), 1.82 (s, 1H; Me); 13C NMR (101 MHz, CDCl3): d=163.5
(C=O), 151.4 (C=O), 138.0, 136.9, 136.6, 134.3 (C6), 128.7, 128.6,
128.3, 128.3, 128.1, 128.0, 127.7, 127.7, 127.6, 109.4 (C5), 94.6 (C1’),
85.7 (C4’), 84.8 (C3’), 80.4 (C2’), 74.0 (CH2), 72.3 (CH2), 72.0 (CH2),
70.5, 70.3 (C5’), 13.2 (Me); elemental analysis calcd (%) for
C32H34N2O7: C 68.80, H 6.13, N 4.69; found: C 68.50, H 5.76, N 4.69;
ESI-HRMS: m/z 581.2279 ([M+Na]+, C32H34N2O7·Na calcd 581.2259).
1-(2-Deoxy-5-O-(4,4’-dimethoxytrityl)-2-fluoro-a-l-ribofurano-
syl)thymine (7): Compound 6 (229 mg, 0.88 mmol) was coevapo-
rated with anhyd. pyridine (2ꢂ5 mL) and redissolved in anhyd.
pyridine (5 mL). 4,4’-Dimethoxytrityl chloride (DMTrCl, 386 mg,
1.14 mmol) was added and the resulting mixture was stirred for
3 h at room temperature. EtOH (0.5 mL) was added and stirring
was continued for additional 10 min followed by evaporation to
dryness under reduced pressure. The residue was redissolved in
CH2Cl2 (100 mL) and washed successively with sat. aq. NaHCO3
(25 mL) and brine (25 mL). The organic phase was dried (Na2SO4),
filtered and evaporated to dryness under reduced pressure. The
residue was purified by silica gel column chromatography by using
as eluent EtOAc (50–100%) in PE to afford nucleoside 7 as a white
1-(2-Deoxy-3,5-di-O-benzyl-2-fluoro-a-l-ribofuranosyl)-3-(benzyl-
oxymethyl)thymine (5): Compound 4 (1.50 g, 2.69 mmol) was co-
evaporated with anhyd. toluene (2ꢂ20 mL) and redissolved in
anhyd. toluene (25 mL) and the resulting mixture was stirred at
room temperature. Anhyd. pyridine (1.1 mL, 13.5 mmol) and
deoxo-fluor (50% in toluene, 3.9 mL, 10.8 mmol) were added and
the reaction was stirred for 20 h at room temperature. The reaction
mixture was diluted with EtOAc (100 mL) and washed successively
with sat. aq. NaHCO3 (50 mL) and brine (50 mL). The organic phase
was dried (Na2SO4), filtered and evaporated to dryness under re-
duced pressure. The residue was purified by silica gel column chro-
matography by using as eluent EtOAc (0–50%) in PE to afford
1
foam (448 mg; 88%). H NMR (400 MHz, CDCl3): d=9.53 (brs, 1H;
NH), 7.49–7.41 (m, 2H), 7.37–7.17 (m, 8H), 6.86–6.78 (m, 4H), 5.80
(d, J=17.8 Hz, 1H; H1’), 5.32 (d, J=50.2 Hz, 1H; H2’), 4.53–4.38 (m,
2H; H3’ and H4’), 3.78 (s, 6H; 2ꢂOMe), 3.73 (d, J=5.7 Hz, 1H;
3’OH), 3.31 (dd, J=9.0, 6.2 Hz, 1H; H5’a), 3.24 (dd, J=10.2, 5.3 Hz,
1H; H5’b), 1.89 (d, J=1.1 Hz, 3H; Me); 19F NMR (376 MHz, CDCl3):
d=À181.4; elemental analysis calcd (%) for C31H31FN2O7·1= EtOAc:
4
C 65.74, H 5.69, N 4.79; found: C 65.38, H 5.63, N 4.75; ESI-HRMS:
m/z 585.2010 ([M+Na]+, C31H31FN2O7·Na calcd 585.2008).
1
compound 5 as a colorless oil (775 mg; 50%). H NMR (400 MHz,
CDCl3): d=7.39–7.18 (m, 15H; Ph), 7.15 (d, J=1.2 Hz, 1H; H6), 6.11
(dd, J=16.2, 1.3 Hz, 1H; H1’), 5.48 (q, J=9.7 Hz, 2H; NCH2), 5.17
(dt, J=49.8, 1.4 Hz, 1H; H2’), 4.71–4.54 (m, 7H; H4’ and 3ꢂOCH3),
4.26–4.18 (m, 1H; H3’), 3.62 (ddd, J=10.1, 6.0, 1.8 Hz, 1H; H5’a),
3.54 (ddd, J=10.1, 6.4, 1.2 Hz, 1H; H5’b), 1.83 (d, J=1.2 Hz, 3H;
Me); 13C NMR (101 MHz, CDCl3): d=163.3 (C=O), 150.9 (C=O),
138.0, 137.6, 136.4, 134.6 (C6), 128.6, 128.5, 128.4, 128.3, 128.3,
127.9, 127.8, 127.8, 127.7, 109.8 (C5), 97.7 (d, J=187.6 Hz, C2’), 91.1
(d, J=37.1 Hz, C1’), 85.5 (C4’), 81.6 (d, J=25.5 Hz, C3’), 73.6, 72.3,
72.3, 70.5, 69.2 (d, J=2.6 Hz, H5’), 13.1 (Me); 19F NMR (376 MHz,
1-(3-O-(2-Cyanoethoxy(diisopropylamino)phosphino)-2-deoxy-5-
O-(4,4’-dimethoxytrityl)-2-fluoro-a-l-ribofuranosyl)thymine (8):
Compound 7 (104 mg, 0.18 mmol) was coevaporated with 1,2-DCE
and redissolved in anhyd. CH2Cl2 (5 mL) and the resulting mixture
was stirred under argon at room temperature. Diisopropyl ammo-
nium tetrazolide (46 mg, 0.27 mmol) and bis(N,N-diisopropylami-
no)-2-cyanoethoxyphosphine (85 mL, 0.27 mmol) were added and
stirring was continued for 18 h at room temperature. The resulting
mixture was diluted with sat. aq. NaHCO3 (25 mL) and extracted
with CH2Cl2 (2ꢂ50 mL). The combined organic phase was dried
ChemBioChem 2011, 12, 1904 – 1911
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1909